BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galindo CM, Oliveira Ganzella FAD, Klassen G, Souza Ramos EAD, Acco A. Nuances of PFKFB3 signaling in breast cancer. Clinical Breast Cancer 2022. [DOI: 10.1016/j.clbc.2022.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lv L, Yang S, Zhu Y, Zhai X, Li S, Tao X, Dong D. Relationship between metabolic reprogramming and drug resistance in breast cancer. Front Oncol 2022;12:942064. [DOI: 10.3389/fonc.2022.942064] [Reference Citation Analysis]
2 Yu H, Dai C, Zhu W, Jin Y, Wang C, Li X. PFKFB3 Increases IL-1β and TNF-α in Intestinal Epithelial Cells to Promote Tumorigenesis in Colitis-Associated Colorectal Cancer. Journal of Oncology 2022;2022:1-8. [DOI: 10.1155/2022/6367437] [Reference Citation Analysis]
3 Tőkés AM, Vári-kakas S, Kulka J, Törőcsik B. Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas. Front Oncol 2022;12:850401. [DOI: 10.3389/fonc.2022.850401] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]